FDA.reportPublic FDA data

Anticardiolipin antibody IVD, control

Definition
A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of one or multiple classes of antibodies to cardiolipin in a clinical specimen.
GUDID devices
7
Last updated
2026-07-30 21:30:59

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
08430793040778Aptiva® APS IgG ControlsINOVA DIAGNOSTICS, INC.7251022024-03-11
08430793040914Aptiva® APS IgM ControlsINOVA DIAGNOSTICS, INC.7251422024-03-11
08426950554486QUANTA Flash® aCL IgG ControlsINOVA DIAGNOSTICS, INC.7012322016-08-31
08426950594994QUANTA Flash® aCL IgM ControlsINOVA DIAGNOSTICS, INC.7012372016-08-31
08426950597483QUANTA Flash® aCL IgA ControlsINOVA DIAGNOSTICS, INC.7012272016-08-31
08426950496991HemosIL AcuStar Anti-Cardiolipin IgG ControlsINSTRUMENTATION LABORATORY COMPANY00098021042016-09-23
08426950497004HemosIL AcuStar Anti-Cardiolipin IgM ControlsINSTRUMENTATION LABORATORY COMPANY00098021082016-09-23